Hasegawa Tomoko

Hasegawa Kei, Suda Kenji, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Miyake Masahiro et al.

Suda Kenji, Miyake Masahiro, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Hasegawa Tomoko et al.

This study found longer axial length (≥27.7mm) correlates with advanced visual field loss in young POAG patients, highlighting its clinical significance for assessing severe glaucoma risk.

Ikeda Hanako O, Hasegawa Tomoko, Abe Hiroyasu, Amino Yoko, Nakagawa Takayuki, Tada Harue et al.

Oral BCAAs for retinitis pigmentosa showed no significant visual field benefit, but a trend toward slower retinal degeneration was observed. BCAAs were safe, warranting further larger studies.

Iwai Sachiko, Hasegawa Tomoko, Ikeda Hanako Ohashi, Tsujikawa Akitaka

BCAAs were studied for their ATP-boosting mechanism. They promote glucose transporter translocation to the cell surface, increasing glucose uptake and ATP production, which is relevant for treating glaucoma and retinal degeneration.

Kido Ai, Miyake Masahiro, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Suda Kenji et al.

This study found topical beta-blockers for glaucoma did not significantly increase asthma attacks in patients with asthma, suggesting they might be an option when other treatments fail.

Suda Kenji, Akagi Tadamichi, Ikeda Hanako Ohashi, Kameda Takanori, Hasegawa Tomoko, Miyake Masahiro et al.

Atopic dermatitis linked to severe visual field loss in younger glaucoma patients on steroids. This highlights the need for earlier, reinforced eye screening in atopic dermatitis patients.

Yoshikawa Munemitsu, Nakanishi Hideo, Yamashiro Kenji, Miyake Masahiro, Akagi Tadamichi, Gotoh Norimoto et al.

This study found the CDKN2B gene is linked to specific retinal nerve fiber layer thinning and corresponding paracentral/lower visual field defects in glaucoma, aiding detailed genetic risk assessment.

Hasegawa Tomoko, Ooto Sotaro, Takayama Kohei, Makiyama Yukiko, Akagi Tadamichi, Ikeda Hanako O et al.

This study found cone photoreceptor integrity (density, organization) was preserved in glaucoma patients, even with visual field loss, suggesting cones are resilient. This challenges assumptions about early cone damage.

Akagi Tadamichi, Iida Yuto, Nakanishi Hideo, Terada Noriko, Morooka Satoshi, Yamada Hiroshi et al.

Glaucoma patients with hemifield visual field defects showed region-specific microvascular reduction in the peripapillary retina and partially in the optic disc, correlating with visual field loss. This suggests microvascular changes contribute to glaucoma progression.

Nakanishi Hideo, Akagi Tadamichi, Suda Kenji, Hasegawa Tomoko, Yamada Hiroshi, Yokota Satoshi et al.

This study clustered combined visual field points and RNFL sectors in glaucoma, finding significant correlations that support the function-structure relationship, aiding understanding of glaucomatous damage patterns.

Nakanishi Hideo, Akagi Tadamichi, Hangai Masanori, Kimura Yugo, Suda Kenji, Hasegawa Tomoko et al.

Studying axial length's effect on mGCC thickness and glaucoma diagnosis, researchers found axial length impacts mGCC, and current SD-OCT normative databases misdiagnose highly myopic eyes, even with magnification correction.

Yamada Hiroshi, Akagi Tadamichi, Nakanishi Hideo, Ikeda Hanako O, Kimura Yugo, Suda Kenji et al.

This study found that peripapillary atrophy with Bruch's membrane (PPA+BM) is linked to faster visual field progression in glaucoma, while PPA without Bruch's membrane (PPA-BM) may be protective. This microstructure helps predict glaucoma worsening.

Hasegawa Tomoko, Akagi Tadamichi, Hangai Masanori, Yamada Hiroshi, Suda Kenji, Kimura Yugo et al.

This study found that in glaucomatous eyes, the deep scleral opening is nasally shifted from Bruch's membrane opening, correlating with disc tilt and axial length. This informs glaucoma assessment, especially in myopic, tilted discs.

Suda Kenji, Hangai Masanori, Akagi Tadamichi, Noma Hisashi, Kimura Yugo, Hasegawa Tomoko et al.

This study found functional (SAP) and structural (OCT) glaucoma tests detect progression differently, highlighting their complementary roles in monitoring optic nerve damage over time.